Chinese-made COVID-19 vaccines have come under scrutiny after regulators approved the first one for general use on Dec. 31 last year. Several Chinese pharmaceutical companies are still conducting clinical trials for their products.
A contraindication is a symptom or condition that makes treatment risky and potentially inadvisable.
